Registry-listed formulations

This catalogue entry has no confirmed scientific concept.

Each study is counted once in the molecule profile. Registry products remain separate. Naming an ingredient does not establish that products are interchangeable or what participants received.

2 source entries across 2 studies. This list may not include all unresolved or historical entries.

18F-PF-06445974Registry intervention
Linked study entry; product equivalence not established
View study and source
18F-PF-06445974Registry intervention
Linked study entry; product equivalence not established
View study and source

Success Metrics

Active Trials

3(100%)

Phase Distribution

Phase 1

100%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution3 total trials

Phase 1Safety & dosage

3(100.0%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Active(3)

Detailed Status

Recruiting3

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

N/A

Most Advanced

Phase 1

Trials by Phase

Phase 13 (100.0%)

Trials by Status

recruiting3100%

Recent Activity

3 active trials

Showing 3 of 3

recruitingphase_1

Clinical Trials (3)

Showing 3 of 3 trials

NCT06795581Phase 1

PET Imaging of Phosphodiesterase-4B (PDE4B) in Alcohol Use Disorder

Recruiting

NCT05703685Phase 1

[18F]PF-06445974 to Image PDE4B in Major Depressive Disorder Using PET

Recruiting

NCT07027839Phase 1

Acute Effects of Alcohol on PET Imaging of Phosphodiesterase-4B (PDE4B)

Recruiting

All 3 trials loaded

Drug Details

Intervention Type: Drug
Total Trials: 3